Workflow
Hagens Berman Scrutinizing F5 (FFIV) Over Alleged Long-Term Undetected Hack and Nation State Infiltration
Prnewswire· 2026-02-09 13:40
Partner Reed Kathrein Scrutinizing Claims of Best in Industry Security Against Revealed Source Code Theft; Feb. 17 Deadline SAN FRANCISCO, Feb. 9, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing notice to investors in F5, Inc. (NASDAQ: FFIV) regarding the February 17, 2026, lead plaintiff deadline in a pending securities class action against the company and certain of its executives. FFIV Case Summary at a Glance | Key Detail | Information for FFIV Investors | | --- | --- ...
Noble Grants RSUs
Thenewswire· 2026-02-09 13:40
Core Viewpoint - Noble Mineral Exploration Inc. has announced the grant of 3,330,000 restricted share units (RSUs) to its officers, directors, and certain consultants, effective February 6, 2026, as part of its equity incentive plan [1][3]. Group 1: RSU Grant Details - The total of 3,330,000 RSUs includes 1,650,000 RSUs granted specifically to directors and officers of the Company [2]. - The RSUs will vest one year after the grant date and can be settled in common shares, cash equivalents, or a combination of both [2]. - The grant is compliant with the TSX Venture Exchange requirements, and the Company now has a total of 3,330,000 RSUs outstanding [3]. Group 2: Company Overview - Noble Mineral Exploration Inc. is a Canadian junior exploration company with holdings in various nickel and gold exploration properties [4]. - The Company holds mineral and exploration rights over approximately 70,000 hectares in Northern Ontario and 24,000 hectares in Quebec, with plans for option/joint venture exploration programs [5]. - Notable projects include Project 81, which has diversified drill-ready targets, and several other properties across Ontario and Quebec, including uranium and rare earth element properties [6].
Gold Pops Back Above $5,000. Blame China for Volatility, Says Bessent.
Barrons· 2026-02-09 13:39
The yellow metal looks to be settling after recent price swings. ...
My Top 8 Tech Picks For Income Amid The AI Correction
Seeking Alpha· 2026-02-09 13:39
Core Viewpoint - The current period is an exciting time for tech analysts, particularly in the context of the ongoing AI revolution, which presents numerous opportunities for investment in tech stocks [1]. Group 1: Analyst Perspective - The analysis focuses on tech stocks that are personally interesting for portfolio addition, indicating a hands-on approach to investment [1]. - The writing is tailored for both beginners and advanced readers, aiming to provide a clear and well-reasoned perspective on the tech sector [1]. Group 2: Disclosure Information - The analyst holds a beneficial long position in shares of IBM, QCOM, DELL, and MSFT, either through stock ownership, options, or other derivatives [2]. - The article reflects the analyst's personal opinions and is not influenced by compensation from any company mentioned [2].
Citi Raises Price Target on Ball Corporation (BALL) to $74 and Reiterates a Buy Rating
Yahoo Finance· 2026-02-09 13:37
Core Viewpoint - Ball Corporation is recognized as one of the 10 Most Profitable Undervalued Stocks to Buy, with analysts raising price targets following strong fourth-quarter results and a positive outlook for 2026 and 2027 [1][8]. Analyst Ratings and Price Targets - Citi analyst Anthony Pettinari increased the price target for Ball Corporation to $74 from $67, maintaining a Buy rating due to strong fourth-quarter results and a compelling outlook [1]. - Truist raised its price target to $75 from $69 while keeping a Buy rating, noting a 9% post-earnings stock movement reflecting increased investor confidence in the company's execution and focus on profitable growth under new CEO Ron Lewis [2]. - RBC Capital lifted its target to $74 from $67 and reiterated an Outperform rating, citing a fourth-quarter earnings beat driven by robust volumes [2]. - BofA raised its price target to $71 from $63 and maintained a Buy rating, while also increasing FY2026 and FY2027 EPS forecasts [3]. - UBS increased its target to $66 from $58 and maintained a Neutral rating after updating its model post-earnings [3]. - Morgan Stanley raised its price target to $66 from $63, keeping an Equal Weight rating, citing improved clarity on operating leverage into 2027 [3]. Financial Performance - Ball Corporation reported fourth-quarter revenue of $3.35 billion, exceeding the consensus estimate of $3.11 billion [4]. - The company achieved robust volume growth in the quarter and returned approximately $1.54 billion to shareholders through share repurchases and dividends [4]. Company Overview - Ball Corporation supplies aluminum packaging products for the beverage, personal care, and household products industries, operating in the United States, Brazil, and internationally [5]. - The company manufactures and sells aluminum beverage containers to fillers of carbonated soft drinks, beer, energy drinks, and other beverages [5].
EDM Resources submits key federal permit application for Scotia Mine pit extension
Proactiveinvestors NA· 2026-02-09 13:37
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
WSJ· 2026-02-09 13:37
Core Insights - Eli Lilly has agreed to acquire Orna Therapeutics, a genetic-medicine biotechnology company, for a total consideration of up to $2.4 billion in cash [1] Company Summary - The acquisition reflects Eli Lilly's strategic focus on expanding its capabilities in genetic medicine [1] - Orna Therapeutics specializes in innovative genetic therapies, which aligns with Eli Lilly's growth objectives in the biotechnology sector [1] Financial Implications - The deal is valued at up to $2.4 billion, indicating a significant investment by Eli Lilly in the biotechnology space [1]
Diversified Royalty Corp. Announces Closing of $60 Million Bought Deal Offering of 5.75% Convertible Unsecured Subordinated Debentures
Globenewswire· 2026-02-09 13:37
Core Viewpoint - Diversified Royalty Corp. has successfully closed a public offering of $60 million in convertible unsecured subordinated debentures, which will be used for debt repayment, funding royalty pool additions, and general corporate purposes [1][3]. Group 1: Offering Details - The offering consisted of $60 million aggregate principal amount of 5.75% convertible unsecured subordinated debentures priced at $1,000 each [1]. - A syndicate of underwriters, led by CIBC Capital Markets and Desjardins Securities Inc., conducted the offering, with an option for an additional $9 million in debentures for over-allotments [2]. - The debentures will trade on the Toronto Stock Exchange under the symbol "DIV.DB.B" [6]. Group 2: Financial Terms - The debentures mature on March 31, 2031, with a 5.75% annual interest rate payable semi-annually starting September 30, 2026 [4]. - The conversion price for the debentures into common shares is set at $5.35, subject to adjustments [4]. - The first interest payment will be approximately $36.74 per $1,000 principal amount of debentures [5]. Group 3: Use of Proceeds - Net proceeds from the offering will be allocated to repay outstanding amounts under the acquisition facility, which will increase available funds for future acquisitions [3]. - The funds will also support expected additions to the royalty pools of certain royalty partners and be used for working capital and general corporate purposes [3]. Group 4: Company Overview - Diversified Royalty Corp. is a multi-royalty corporation focused on acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America [8]. - The company aims to increase cash flow per share through accretive royalty purchases and intends to maintain a stable monthly dividend for shareholders [11].
Keefe Bruyette Raises its Price Target on The Hartford Insurance Group (HIG) to $163 and Maintains an Outperform Rating
Yahoo Finance· 2026-02-09 13:36
Views from other firms were more measured but moved in the same direction following the earnings release. After updating models to reflect fourth-quarter results, Citi and Morgan Stanley both raised their price targets on February 4 and February 3, 2026, respectively, while maintaining Neutral and Equal Weight ratings. The firms cited improved visibility around capital returns and net interest income, partially offset by slightly lower combined ratio expectations for 2026 and 2027. On January 30, 2026, the ...
RBC Capital Raises its Price Target on Ameriprise Financial, Inc. (AMP) to $605 and Reiterates an Outperform Rating
Yahoo Finance· 2026-02-09 13:36
Ameriprise Financial, Inc. (NYSE:AMP) is included among the 10 Most Profitable Undervalued Stocks to Buy On February 2, 2026, RBC Capital analyst Kenneth Lee raised his price target on Ameriprise Financial, Inc. (NYSE:AMP) to $605 from $580 and reiterated an Outperform rating following the company's fourth-quarter earnings report. RBC highlighted stronger-than-expected wrap flows in the Advice and Wealth Management segment, noting that organic growth from existing advisors was the primary driver, with some ...